⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ccnd2 gene amplification

Every month we try and update this database with for ccnd2 gene amplification cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung CancerNCT02785939
CCND1 Gene Ampl...
CCND2 Gene Ampl...
CCND3 Gene Ampl...
CDK4 Gene Ampli...
Recurrent Squam...
Stage IV Squamo...
Docetaxel
Laboratory Biom...
Palbociclib
18 Years - SWOG Cancer Research Network
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung CancerNCT02785939
CCND1 Gene Ampl...
CCND2 Gene Ampl...
CCND3 Gene Ampl...
CDK4 Gene Ampli...
Recurrent Squam...
Stage IV Squamo...
Docetaxel
Laboratory Biom...
Palbociclib
18 Years - SWOG Cancer Research Network
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung CancerNCT02785939
CCND1 Gene Ampl...
CCND2 Gene Ampl...
CCND3 Gene Ampl...
CDK4 Gene Ampli...
Recurrent Squam...
Stage IV Squamo...
Docetaxel
Laboratory Biom...
Palbociclib
18 Years - SWOG Cancer Research Network
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: